Clinical Trial Update: INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

View source ↗

Summary

A terminated Alnylam-sponsored study (INSIGHT-AHP) sought to characterize the prevalence of acute hepatic porphyrias among patients with clinical features consi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ala Dehydratase Deficiency Porphyria
• Hepatic Porphyrias
• Hereditary Coproporphyria
• Intermittent Porphyria
• Variegate Porphyria

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Acute Hepatic Porphyria, Hepatic Porphyrias | Status: TERMINATED